ChronoFast: Time-restricted Feeding as a Dietary Strategy Against Metabolic Disturbances in Humans
Study Details
Study Description
Brief Summary
This human dietary intervention study with a cross-over design aims to compare the effects of two isocaloric diets - early time-restricted feeding (TRF) vs. late TRF - on glycemic control and lipid metabolism in overweight and obese women.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
The participants are randomly allocated to one of two study groups: In study group (A) participants will begin with the early TRF (e-TRF) intervention. They will consume their habitual food (and the habitual daily amount of food) between 8 am and 4 pm for two weeks. After a washout-phase participants will conduct the late TRF (l-TRF) and consume their habitual food between 1 pm and 9 pm for another two weeks. Study group (B) receives the same interventions in the reversed order. Both dietary regimens will result in 8-hr eating period and 16-hr fasting period during the 24h day.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Early Time-Restricted Feeding
|
Behavioral: Early Time-Restricted Feeding
Eat between 8 am and 4 pm for two weeks
Other Names:
|
Experimental: Late Time-Restricted Feeding
|
Behavioral: Late Time-Restricted Feeding
Eat between 1 pm and 9 pm for two weeks
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Insulin sensitivity [2 weeks]
Assessed using Matsuda index in oral glucose tolerance test (OGTT)
Secondary Outcome Measures
- Glucose tolerance, fasting glucose, and overall daily glycemic variation [1-2 weeks]
Assessed by glucose area under the curve in OGTT and using a continuous glucose monitoring system
- Metabolic hormones and inflammatory markers [2 weeks]
Levels of hormones related to the glucose metabolism, hormones of appetite regulation, adipokines and inflammatory markers
- Blood lipids [2 weeks]
Total cholesterol, low-density lipoprotein and high-density lipoprotein cholesterol and triglycerides
- Satiety and hunger scores [2 weeks]
Assessed using Visual Analog Scales (VAS with a scale of 1-100, where higher values correspond to stronger satiety/hunger)
- Sleep quality and duration [1-2 weeks]
Assessed by the Pittsburgh Sleep Quality Index (PSQI score, which ranges from 0-21, where higher values correspond to worse sleep quality) and also monitored by an ActiGraph device
- Physical activity [7 days]
24-h physical activity will be monitored by an ActiGraph device
- Expression of metabolic genes in adipose tissue [2 weeks]
RNA-Seq analysis of subcutaneous adipose tissue samples
- Social and economic decision behaviour [2 weeks]
Assessed by computer tests together with the Barratt Impulsiveness Scale short version (BIS-15 with a score between 15 and 60, where higher values correspond to higher impulsiveness) and the UCLA Loneliness Scale (with a score between 20 and 100, where higher values correspond to higher subjectively perceived loneliness)
Eligibility Criteria
Criteria
Inclusion Criteria:
- BMI 25-35 kg/m²
Exclusion Criteria:
-
prior diagnosis of type 1 or 2 diabetes
-
weight changes > 5% within past 3 months
-
current shift work or history of shift work
-
traveled across more than one time zone one month before the study
-
poor quality of sleep (PSQI score>10)
-
eating disorders, food intolerance/allergy, severe indigestion
-
Pregnant or breastfeeding
-
severe internal or psychiatric disorders or other conditions that might influence the outcome of the study
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | German Institute of Human Nutrition Potsdam-Rehbruecke | Nuthetal | Germany | 14558 |
Sponsors and Collaborators
- German Institute of Human Nutrition
- Charite University, Berlin, Germany
- Immanuel Krankenhaus Berlin, Germany
- Hasso-Plattner Institut, Potsdam, Germany
- University of Potsdam
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- DFG RA 3340/3-1